key: cord-0911422-lck9l8yg
authors: Arleo, Timothy; Cheeley, Justin
title: Pyoderma Gangrenosum Faciale in a Patient with Crohn’s Disease
date: 2020-06-21
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2020.06.026
sha: 89cb0cdc27b79d1131b61937557e75a39f6e4057
doc_id: 911422
cord_uid: lck9l8yg

nan

The patient was later hospitalized with a productive cough progressing to worsening hoarseness and 98 hemoptysis. A CT chest demonstrated multifocal centrilobular nodular airspace opacities predominantly 99 in the right upper lobe, concerning for multifocal pneumonia, chemical pneumonitis, or extracutaneous 100 PG. She was given antimicrobial treatment, and azathioprine and infliximab were held during 101 hospitalization. Following discharge, her facial PG and constitutional symptoms worsened. Given the 102 option between resuming her immunomodulatory therapies with close monitoring or to re-admit for 103 infection rule-out, the patient chose the former. Her condition stabilized and improved. However, 104 following a trip to New York City in February 2020, the patient and her parents suffered from new onset 105 fevers, diarrhea, and cough. While her parents recovered, the patient complained of severe shortness of 106 breath and died at home presumably due to COVID-19. 107 108 Discussion: 109 PG is difficult to diagnose due to variable presentation, overlap with other conditions, and absence of 110 pathognomonic laboratory and histologic findings. Our patient met 1 major and 4 minor criterion for 111 ulcerative PG (biopsy demonstrating neutrophilic infiltrate; infection exclusion; peripheral erythema, 112 undermined border, and tenderness at ulceration site; cribriform scar at healed ulcer sites; decreasing 113 ulcer size within 1 month of immunosuppressants), yielding a specificity of 90% for PG 3 . 114

Facial and perianal PG are exceedingly rare. Only 4.5% of 356 patients or 7.8% of 103 patients present 115 with facial involvement 1,2 . We found only two other cases of perianal PG after conducting a PubMed 116 review using the terms "Pyoderma gangrenosum AND perianal" 4-5 . 117

As PG is associated with an underlying disease in 50-78% of patients, most commonly inflammatory 118 bowel disease (IBD), investigation into a comorbid condition is warranted 6 . Endoscopic and histologic 119 confirmation of IBD may be difficult in patients presenting with acute PG due to intolerance of or 120 inadequate bowel preparation, timing of immunosuppressive therapies that blunt diagnostic sensitivity 121 of gastrointestinal histology, and gastroenterologist willingness to pursue invasive tests in the absence 122 of symptoms.

Our patient's history of aphthous ulcers, iron deficiency anemia, and perianal disease commonly present 124 in patients with CD 7 . A meta-analysis of over 1,300 patients with and without suspected CD indicate a 125 pooled ASCA sensitivity of 55% (95% CI: 52-59) and pooled specificity of 93% (95% CI: 91-95) for CD 8 . 126

Diagnosis of underlying IBD may afford insurance coverage of FDA-approved immunomodulatory 127 therapies that may not otherwise be supported for PG alone. 128 PG most commonly presents extracutaneously in the lungs and typically affects 30-to 60-year-old 129 women. Symptoms are variable, and most commonly include fever and cough, while other signs of 130 respiratory involvement, such as dyspnea, crackles, and stridor, are reported less frequently 9,10 . Chest 131 radiograph and CT can reveal non-cavitating or cavitating infiltrates or pulmonary nodules. Given the 132 rarity of pulmonary PG and its variable presentation, no clinical guidelines exist for diagnosis and 133 treatment 10 . A differential of granulomatosis with polyangiitis (GPA), infection, and malignancy is 134 typically considered. Our patient's delayed swallowing trigger and incomplete laryngohyoid elevation 135 from PG-induced cranial nerve dysfunction increase her aspiration risk. Therefore, respiratory symptoms 136 and pulmonary infiltrates, as well as reasonable rule-out of GPA, suggest a differential diagnosis of 137 infectious pneumonia, chemical pneumonitis, or pulmonary PG. Misdiagnosis can prove deadly, as 138 reducing immunosuppressive treatment may cause a pulmonary PG flare, while continuing 139 immunosuppressants allows progression of aspiration pneumonia or chemical pneumonitis. 140

Herein we present an unusual case of facial and perianal PG in a patient with occult underlying CD 141 complicated by pulmonary disease of uncertain etiology. Patients with PG faciale should be assessed for 142 dysphagia, and pulmonary disease must be adequately investigated to determine best management 143 strategies. 144 145

Pyoderma Gangrenosum: A 148 Retrospective Review of Patient Characteristics, Comorbidities and Therapy in 103 Patients

The Association of Age With Clinical Presentation and Comorbidities of Pyoderma 154

Diagnostic Criteria of Ulcerative Pyoderma 158 Gangrenosum: A Delphi Consensus of International Experts

Perianal Pyoderma Gangrenosum after Excision and Fulguration of Anal Condyloma 162

Gangrenosum with Extensive Perianal Involvement

Etiology and Management of Pyoderma

Extraintestinal Manifestations of 173

Inflammatory Bowel Disease: Epidemiology, Diagnosis, and Management

Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and 176 perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease

Extracutaneous 179 Involvement of Pyoderma Gangrenosum

Gangrenosum with Pulmonary Involvement: Clinical Presentation, Diagnosis and Management

eschar. An oral cavity opening is still present. 205